2567929-06-8
Chemical Structure
Cap-dependent endonuclease-IN-19
- CAS No.: 2567929-06-8
- Formula:C28H31N3O4
- Molecular Weight:473.56
IUPAC Name: tert-butyl (3-((2-(4-((tert-butoxycarbonyl)amino)-1,2,5-oxadiazol-3-yl)-4-(3-((tert-butyldimethylsilyl)oxy)prop-1-yn-1-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-7-yl)oxy)propyl)carbamate
InChIKey: PZXLRBVTCCFKGJ-UHFFFAOYSA-N
SMILES: O=C1C=CN2C(C(N(C3(CCCCC3)N2C(C4=CC=CC=C4)C5=CC=CC=C5)CCOC)=O)=C1O
Biological Activity: Cap-dependent endonuclease-IN-19 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-19 is a spirocyclic pyridone derivative. Cap-dependent endonuclease-IN-19 has strong inhibitory effect on RNA polymerase activity of A virus (extracted from patent CN111410661A, compound 1)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Cap-dependent endonuclease-IN-19 | Cap-dependent endonuclease-IN-19 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-19 is a spirocyclic pyridone derivative. Cap-dependent endonuclease-IN-19 has strong inhibitory effect on RNA polymerase activity of A virus (extracted from patent CN111410661A, compound 1). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
